Ken Fisher’s Top 30 Long Positions, Q3/2012

By   |  Stock Markets  |  Dec 25, 2012 09:12AM GMT  |  Add a Comment
 
Kenneth Fisher is an American businessman, founder and chairman as well as CEO of Fisher Investments, a money management firm headquartered in California. Fisher writes the monthly “Portfolio Strategy” column in Forbes magazine. Ken Fisher is one of the richest Americans and part of the Forbes 400 list of world billionaires. Funds run by Ken Fisher at Fisher Asset Management were valued at USD 34.91 billion.

Here is a list of his top 30 investment positions as of September 30, 2012. During the quarter Q3/2012, Ken Fisher had 458 total positions.

Top New Buys: CMCSA, PBR, TM, RY, NVS, VOD, CHL, NTGR, SAM, WRC

GlaxoSmithKline (GSK) has a market capitalization of $107.56 billion. The company employs 97,389 people, generates revenue of $44.150 billion and has a net income of $8.798 billion. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $14.844 billion. The EBITDA margin is 33.62 percent (the operating margin is 28.50 percent and the net profit margin 19.93 percent).

Financial Analysis: The total debt represents 36.27 percent of the company’s assets and the total debt in relation to the equity amounts to 185.52 percent. Due to the financial situation, a return on equity of 62.19 percent was realized. Twelve trailing months earnings per share reached a value of $3.20. Last fiscal year, the company paid $2.26 in the form of dividends to shareholders.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 13.66, the P/S ratio is 2.42 and the P/B ratio is finally 8.48. The dividend yield amounts to 5.31 percent and the beta ratio has a value of 0.65.

Long-Term Stock History Chart Of GlaxoSmithKline
 Long-Term Stock History Chart Of GlaxoSmithKline


Long-Term Dividends History of GlaxoSmithKline
 Long-Term Dividends History of GlaxoSmithKline


Long-Term Dividend Yield History of GlaxoSmithKline
 Long-Term Dividend Yield History of GlaxoSmithKline

Pfizer (PFE) has a market capitalization of $184.65 billion. The company employs 103,700 people, generates revenue of $67.425 billion and has a net income of $8.739 billion. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $23.011 billion. The EBITDA margin is 34.13 percent (the operating margin is 18.93 percent and the net profit margin 12.96 percent).

Financial Analysis: The total debt represents 20.72 percent of the company’s assets and the total debt in relation to the equity amounts to 47.39 percent. Due to the financial situation, a return on equity of 10.24 percent was realized. Twelve trailing months earnings per share reached a value of $1.25. Last fiscal year, the company paid $0.80 in the form of dividends to shareholders.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 20.03, the P/S ratio is 2.74 and the P/B ratio is finally 2.31. The dividend yield amounts to 3.83 percent and the beta ratio has a value of 0.70.

Long-Term Stock History Chart Of Pfizer
 Long-Term Stock History Chart Of Pfizer


Long-Term Dividends History of Pfizer
 Long-Term Dividends History of Pfizer


 Long-Term Dividend Yield History of Pfizer

General Electric (GE) has a market capitalization of $218.32 billion. The company employs 301,000 people, generates revenue of $147.300 billion and has a net income of $14.366 billion. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $31.015 billion. The EBITDA margin is 21.06 percent (the operating margin is 13.64 percent and the net profit margin 9.75 percent).

Financial Analysis: The total debt represents 63.22 percent of the company’s assets and the total debt in relation to the equity amounts to 389.43 percent. Due to the financial situation, a return on equity of 11.06 percent was realized. Twelve trailing months earnings per share reached a value of $1.35. Last fiscal year, the company paid $0.61 in the form of dividends to shareholders.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 15.45, the P/S ratio is 1.48 and the P/B ratio is finally 1.89. The dividend yield amounts to 3.65 percent and the beta ratio has a value of 1.61.

 Long-Term Stock History Chart Of General Electric


 Long-Term Dividends History of General Electric


 Long-Term Dividend Yield History of General Electric

Take a closer look at all top portfolio positions of Ken Fisher. The average P/E ratio amounts to 19.09. The dividend yield has a value of 2.71 percent. Price to book ratio is 4.03 and price to sales ratio 3.18.

Here are Ken Fisher’s Top 30 Long Positions:

 Top 30 Positions Of Ken Fisher Fund Portfolio Q3-2012


Long-Term Dividends History of GlaxoSmithKline
 Ticker Company

Related stock ticker symbols:
LQD, PFE, JNJ, CSCO, GE, IBM, AXP, V, AMZN, WFC, AAPL, ORCL, NSRGY, SNY, HBC, PEP,
SLB, QCOM, GSK, JPM, GOOG, MSFT, TSM, MCD, RIO, PG, HD, PM, BHP

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data .

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Add a Comment

 

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

 
 
 
 

Successfully Reported

Thank you. This comment has been flagged for a moderator.
_touchLoadingMsg
 
 
CFDs Quotes
 SPX 500 Futures1661.65-2.30-0.14%  
 NQ 100 Futures3019.40-5.20-0.17%  
 US 3015354.79+121.57+0.80%  
 DAX8398.00+28.13+0.34%  
 FTSE 1006723.06+35.26+0.53%  
 Japan 22515138.12+100.88+0.67%  
 US Dollar Index84.28-0.06-0.07%  
CFDs Quotes
 Gold1363.05+5.30+0.39%  
 Silver21.598-0.592-2.67%  
 Copper3.317+0.001+0.04%  
 Crude Oil96.2900%  
 Natural Gas4.128+0.069+1.69%  
 US Cotton No.286.34+0.32+0.37%  
 US Coffee C137.00-3.25-2.32%  
 
 EUR/USD1.2838+0.0005+0.04%  
 GBP/USD1.5184+0.0015+0.10%  
 USD/JPY102.80-0.40-0.39%  
 USD/CHF0.9704-0.0020-0.21%  
 AUD/USD0.9746+0.0010+0.10%  
 USD/CAD1.0275-0.0001-0.01%  
 EUR/GBP0.8455-0.0007-0.08%  
CFDs Quotes
 Euro Bund145.16-0.04-0.03%  
 Euro BTP116.57+0.68+0.59%  
 Euro BOBL126.675+0.060+0.05%  
 UK Gilt117.69-0.35-0.30%  
 US 2 YR T-Note110.25-0.02-0.02%  
 US 10 YR T-Note131.87+0.03+0.02%  
 US 30 YR T-Bond144.07+0.18+0.13%  
Connect to Investing.com
  Central Banks Interest Rates Next Meeting  
  FED0.00%-0.25%Jun 19, 2013 
  ECB0.50%Jun 06, 2013 
  BOE0.50%Jun 06, 2013 
  SNB0.00%Jun 20, 2013 
  RBA2.75%Jun 04, 2013 
  BOC1.00%May 29, 2013 
  RBNZ2.50%Jun 12, 2013 
  BOJ0.10%May 22, 2013